Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
11/27/2003 | CA2486483A1 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
11/27/2003 | CA2486157A1 Opioid and opioid-like compounds and uses thereof |
11/27/2003 | CA2486147A1 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies |
11/27/2003 | CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
11/27/2003 | CA2486106A1 Compounds and methods for inhibiting selectin-mediated function |
11/27/2003 | CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor |
11/27/2003 | CA2486000A1 Use of compounds that are effective as selective opiate receptor modulators |
11/27/2003 | CA2485896A1 Pyridazin-3(2h)-one derivatives as pde4 inhibitors |
11/27/2003 | CA2485736A1 Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives |
11/27/2003 | CA2485592A1 Anti tubercular drug: compositions and methods |
11/27/2003 | CA2485465A1 Methods of treating hepatitis |
11/27/2003 | CA2485214A1 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
11/27/2003 | CA2485212A1 1-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
11/27/2003 | CA2484702A1 Substituted 4-aryl-4h-pyrrolo[2,3-h]chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof |
11/27/2003 | CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone |
11/27/2003 | CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles |
11/27/2003 | CA2484238A1 Annelated pyrrole compounds as proton pump inhibitors for treating ulcer |
11/27/2003 | CA2484233A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
11/27/2003 | CA2483619A1 Novel compounds and their use |
11/27/2003 | CA2483368A1 (s)-4-amino-5-chloro-2-methoxy-n-¬1-¬1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl|-4-piperidinyl|benzamide, process for the preparation thefeof, pharmaceutical composition containing the same, and intermediate therefor |
11/27/2003 | CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands |
11/27/2003 | CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
11/27/2003 | CA2482151A1 Substituted 2-phenyl-3(2h)-pyridazinones |
11/27/2003 | CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
11/26/2003 | EP1365024A1 Traf3-binding b cell-specific receptor |
11/26/2003 | EP1364952A1 Bicyclic nitrogenous fused-ring compound |
11/26/2003 | EP1364949A1 Jnk inhibitor |
11/26/2003 | EP1364943A1 Novel cystine derivatives and inhibitors for the activation of inflammatory factors |
11/26/2003 | EP1364648A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
11/26/2003 | EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes |
11/26/2003 | EP1364023A2 Method of diagnosing and treating cartilage disorders |
11/26/2003 | EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses |
11/26/2003 | EP1363993A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF I$g(k)B KINASE (IKK) |
11/26/2003 | EP1363937A2 Immunomodulating agents from parasitic worms and method for isolation thereof |
11/26/2003 | EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
11/26/2003 | EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
11/26/2003 | EP1363910A2 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
11/26/2003 | EP1363909A2 Tricyclic androgen receptor modulator compounds |
11/26/2003 | EP1363906A2 Heterocyclic inhibitors of erk2 and uses thereof |
11/26/2003 | EP1363904A1 Pyrazoles as tgf inhibitors |
11/26/2003 | EP1363903A1 Indole derivatives and their use as gnrh antagonists |
11/26/2003 | EP1363902A1 Chemical compounds |
11/26/2003 | EP1363901A1 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles |
11/26/2003 | EP1363900A1 Isoindole-imide compounds as tnf-inhibitors |
11/26/2003 | EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
11/26/2003 | EP1363897A2 Antagonists of mcp-1 function and methods of use thereof |
11/26/2003 | EP1363891A2 Anthrone derivatives and their use as jnk inhibitors |
11/26/2003 | EP1363885A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof |
11/26/2003 | EP1363881A2 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
11/26/2003 | EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
11/26/2003 | EP1363875A2 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
11/26/2003 | EP1363663A2 Nucleic acid mucosal immunization |
11/26/2003 | EP1363657A2 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
11/26/2003 | EP1363640A2 Nucleic acid derivatives |
11/26/2003 | EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
11/26/2003 | EP1363632A1 Receptor selective cannabimimetic aminoalkylindoles |
11/26/2003 | EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
11/26/2003 | EP1363629A1 Kappa opioid receptor ligands |
11/26/2003 | EP1363611A1 Retinoid hepatitis therapy |
11/26/2003 | EP1363608A1 Treatment of sleep disturbances |
11/26/2003 | EP1363604A2 Pharmaceutical formulation |
11/26/2003 | EP1363603A1 Method for making water soluble a poorly water-soluble antiseptic |
11/26/2003 | EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs |
11/26/2003 | EP1363557A1 Bioartificial device for storing, cultivating and/or reproducing cells |
11/26/2003 | EP1268487B1 Tricyclic protein kinase inhibitors |
11/26/2003 | EP1259523B1 Pluraflavins and derivatives thereof, process for their preparation and use thereof |
11/26/2003 | EP1176982B1 Prucalopride oral solution |
11/26/2003 | EP1028977B1 Bifidus stimulating peptides and their uses |
11/26/2003 | EP1025096B1 Substituted chroman derivatives |
11/26/2003 | EP1025095B1 Substituted chroman derivatives |
11/26/2003 | EP1007528B1 Robustaflavone, intermediates and analogues and method for preparation thereof |
11/26/2003 | EP1000028B1 Gastrokinetic monocyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
11/26/2003 | EP0964687B1 Pharmaceutical compositions with antimicrobial activity |
11/26/2003 | EP0912601B1 Suppression of immune response via inhibition of cathepsin s |
11/26/2003 | CN1458929A Chemokine receptor binding heterocyclic compounds |
11/26/2003 | CN1458926A Nitric oxide donors based on metallic centres |
11/26/2003 | CN1458845A Pharmaceutical composition comprising condensed indole compound |
11/26/2003 | CN1458839A Dental products comprising bone growth enhancing peptide |
11/26/2003 | CN1458163A Oriental waterplantain rhizome sterol extract and its preparing method and quality control method |
11/26/2003 | CN1457883A Alpha type recombined human interferon suppository and producing process |
11/26/2003 | CN1457873A Process for preparing kidney-tonifying wolfberry fruit capsule |
11/26/2003 | CN1457871A Taiyi liver protection capsule and its preparing method |
11/26/2003 | CN1457867A Medicine powder for clearing away toxic matter and promoting granulation |
11/26/2003 | CN1457862A Paste for treating cardio-cerebral vascular diseases, hepatitis and ruducing blood fat and blood pressure |
11/26/2003 | CN1457854A Health pill for liver |
11/26/2003 | CN1457852A Chinese medicine composition for curing traumatic injury and pains in chest and hypochondrium and its preparing method |
11/26/2003 | CN1457838A Chines medicinal composition for curing hepatitis B |
11/26/2003 | CN1457837A Chinese medicine for curing carcinoma of stomach |
11/26/2003 | CN1457834A Detoxicating pill |
11/26/2003 | CN1457833A Medicinal composition for curing oral and throa diseases and its preparing method, use and quality control method |
11/26/2003 | CN1457829A Chinese medicine composition for curing chronic atrophic sastritis and its preparing method and quality control method |
11/26/2003 | CN1457824A Chinese medicinal pill for reinforcing kidney and strengthening yang, warming and recuperating Qi and blood, and improving crganism immunity |
11/26/2003 | CN1457823A Amomum fruit oil soft capsule |
11/26/2003 | CN1457818A Poison expelling and astheniz resisting balance pill and its preparing method |
11/26/2003 | CN1457816A Ginseng and pilose antler multiple penis pill |
11/26/2003 | CN1457810A Cordate houttuynia preparation and preparing method |
11/26/2003 | CN1457794A New use of picrorhiza rhizome and its iridoid glycoside extract |
11/26/2003 | CN1457790A Process for producing intestinal tract cleaning agent |
11/26/2003 | CN1457778A Subprostrate sophora oral preparation, preparing method and use |
11/26/2003 | CN1457775A Composition containing dihydro myricitrin and myricitrin |